TECHNOLOGY DEVELOPMENT INVESTORS PUBLICATIONS MANAGEMENT & ADVISORS
AAVP is sufficiently financed to file an IND, with capital sourced from institutional, high-net worth and family office investors with a particular focus on the biotechnology space. The Company will raise a round of financing in mid-2018 to fund its planned first in-human Phase 1 clinical trial.